Conmed (CNMD) Tops Q4 EPS by 8c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
CONMED Corporation Announces Fourth Quarter and Full-Year 2020 Financial Results
January 27, 2021 4:05 PM ESTLARGO, Fla.--(BUSINESS WIRE)-- CONMED Corporation (NYSE: CNMD) today announced financial results for the fourth quarter ended December 31, 2020.
Fourth Quarter 2020 Highlights
Sales of $252.8 million decreased 4.5% year over year as reported and 5.2% in constant currency. Domestic revenue decreased 0.7% year over year. International revenue decreased 9.1% as reported year over year and 10.5% in constant currency. Diluted net earnings per share (GAAP) were $0.81, compared to diluted net earnings per share of $0.49 in the fourth quarter of 2019. Adjusted diluted net earnings per share(1) were $0.84 versus adjusted diluted... More